InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Adcock Richard, Chairman & CEO. Director active across 1 companies, notably ImmunityBio, Inc.. Cumulatively, 6 filings have been published. Total volume traded: €109. The latest transaction was disclosed on 5 February 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is free.
Declarations6 total
083,333 shares0
Common Stock
SEC:0001326110-22-000006·
083,333 shares0
Common Stock
SEC:0001326110-22-000006:0·
€547 shares@ €7.78560.0000% mcap100.0% of flow
Common Stock
SEC:0001326110-21-000005·
Ideal exit: 5 Jul 2022 (T+270)
€547 shares@ €7.78560.0000% mcap50.0% of flow
Common Stock
SEC:0001326110-21-000005:0·
Ideal exit: 5 Jul 2022 (T+270)
08,620 shares0
Common Stock
SEC:0001209191-21-055785·
08,620 shares0
Common Stock
SEC:0001209191-21-055785:0·
6 of 6 declarations
About Adcock Richard
Richard Adcock is the Chief Executive Officer of ImmunityBio, Inc. As CEO, he leads the company and is responsible for overall strategy and operations. His leadership is essential for the development and growth of ImmunityBio. Richard Adcock has extensive experience in the medical sector, enabling him to make informed decisions to guide the company towards success.
